Preparation and biological evaluation of polymerizable antibody Fab′ fragment targeted polymeric drug delivery system
- 1 July 2001
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 74 (1-3), 263-268
- https://doi.org/10.1016/s0168-3659(01)00332-7
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer–doxorubicin conjugates in nude miceEuropean Journal Of Cancer, 2001
- HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of actionEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Polymerizable Fab′ antibody fragments for targeting of anticancer drugsNature Biotechnology, 1999
- Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e6 and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenograftsJournal of Controlled Release, 1999
- Design, Synthesis, and Biochemical Evaluation ofN-Substituted Maleimides as Inhibitors of Prostaglandin Endoperoxide SynthasesJournal of Medicinal Chemistry, 1996
- Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivoBioconjugate Chemistry, 1992
- Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerizationEuropean Polymer Journal, 1973